Synthesis of new cocrystal solid form of fluconazole-fumaric acid

Detalhes bibliográficos
Ano de defesa: 2015
Autor(a) principal: Owoyemi, Bolaji Charles Dayo
Orientador(a): Carneiro, Renato Lajarim lattes
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: eng
Instituição de defesa: Universidade Federal de São Carlos
Câmpus São Carlos
Programa de Pós-Graduação: Programa de Pós-Graduação em Química - PPGQ
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
API
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: https://repositorio.ufscar.br/handle/20.500.14289/8557
Resumo: Pharmaceutical cocrystals are multicomponent crystalline solids comprised of an active pharmaceutical ingredient (API) and one or more co-formers interacting through hydrogen bonding or other weak interactions like the π-stack and van der Waals interactions. Fluconazole (FLZ) is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. It is also used to prevent and treat meningitis. Cocrystallization is an alternative approach for enhancement of drug. It can be performed using neat grinding, solvent assisted grinding, solvent evaporation, cooling evaporation and slurry cocrystallization. In this work, a new cocrystal Fluconazol-Fumaric acid monohydrate was synthesized via 1:1 stoichiometric amount of FLZ and FUM at different conditions. The characterization of the synthesized cocrystals was achieved using Raman spectroscopy, differential scanning calorimetry, powder X-ray diffraction and single crystal X-ray diffraction. The results obtained for the characterization of the samples showed some obvious differences among the spectra, diffractograms and thermograms. The single crystal X-ray diffraction analysis of the new structure shows a cocrystal where the fluconazole molecules are attached to the fumaric acid and water molecules respectively through hydrogen bonds, gave unique cell dimensions for an assumed structure C17H18F2N6O6 with a space group of P21/n, a = 17.053(3) Å, b = 5.5995(10), c=21.154(3), α = 90°, β=105.418(4)°, γ= 90°, V = 1947.3(6) Å3. This work is the first to report a monohydrate cocrystal structure of fluconazole and fumaric acid.
id SCAR_05fa728f07f3b923a70a2ddfbbd8eba1
oai_identifier_str oai:repositorio.ufscar.br:20.500.14289/8557
network_acronym_str SCAR
network_name_str Repositório Institucional da UFSCAR
repository_id_str
spelling Owoyemi, Bolaji Charles DayoCarneiro, Renato Lajarimhttp://lattes.cnpq.br/8065852319463976http://lattes.cnpq.br/2811381246113757d09e37ac-a71f-4dee-9e8b-f47bca621de02017-03-13T18:20:51Z2017-03-13T18:20:51Z2015-09-29OWOYEMI, Bolaji Charles Dayo. Synthesis of new cocrystal solid form of fluconazole-fumaric acid. 2015. Dissertação (Mestrado em Química) – Universidade Federal de São Carlos, São Carlos, 2015. Disponível em: https://repositorio.ufscar.br/handle/20.500.14289/8557.https://repositorio.ufscar.br/handle/20.500.14289/8557Pharmaceutical cocrystals are multicomponent crystalline solids comprised of an active pharmaceutical ingredient (API) and one or more co-formers interacting through hydrogen bonding or other weak interactions like the π-stack and van der Waals interactions. Fluconazole (FLZ) is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. It is also used to prevent and treat meningitis. Cocrystallization is an alternative approach for enhancement of drug. It can be performed using neat grinding, solvent assisted grinding, solvent evaporation, cooling evaporation and slurry cocrystallization. In this work, a new cocrystal Fluconazol-Fumaric acid monohydrate was synthesized via 1:1 stoichiometric amount of FLZ and FUM at different conditions. The characterization of the synthesized cocrystals was achieved using Raman spectroscopy, differential scanning calorimetry, powder X-ray diffraction and single crystal X-ray diffraction. The results obtained for the characterization of the samples showed some obvious differences among the spectra, diffractograms and thermograms. The single crystal X-ray diffraction analysis of the new structure shows a cocrystal where the fluconazole molecules are attached to the fumaric acid and water molecules respectively through hydrogen bonds, gave unique cell dimensions for an assumed structure C17H18F2N6O6 with a space group of P21/n, a = 17.053(3) Å, b = 5.5995(10), c=21.154(3), α = 90°, β=105.418(4)°, γ= 90°, V = 1947.3(6) Å3. This work is the first to report a monohydrate cocrystal structure of fluconazole and fumaric acid.Cocristais farmacêuticos são sólidos cristalinos multi-componentes compostos de um ingrediente ativo farmacêutico (API) e um ou mais co-formadores interagindo através de ligações de hidrogênio ou outras interações fracas como as π-stack e Van der Waals. Fluconazol (FLZ), é um fármaco anti-fúngico triazol utilizado no tratamento e prevenção de infecções fúngicas superficiais e sistémicas. É também utilizado para prevenir e tratar a meningite. Cocristalização é uma abordagem alternativa para melhorar as propriedades de fármacos. Pode ser realizada através de moagem a seco, moagem assistida por solvente, evaporação de solvente e cristalização em suspensão. Neste trabalho, um novo co-cristal Fluconazol-Ácido Fumarico monohidrato foi sintetizado utilizando uma estequimetria 1:1 em diferentes condições. A caracterização dos co-cristais sintetizados foi realizada utilizando espectroscopia Raman, calorimetria exploratória diferencial, difração de raios-X em pó é por monocristal. Os resultados obtidos para a caracterização das amostras mostrou algumas diferenças obvias entre os espectros, difratogramas e termogramas. A difração de raios-X de monocristal mostrou uma nova estrutura onde as moléculas de fluconazol estão ligadas ao ácido fumárico e a uma molécula de água através de ligações de hidrogênio, originando uma estrutura única C17H18F2N6O6 de grupo espacial P21/n e dimensões da célula unitária a = 17.053(3) Å, b = 5.5995(10), c=21.154(3), α = 90°, β=105.418(4)°, γ= 90°, V = 1947.3(6) Å3. Este trabalho é o primeiro a relatar uma estrutura de co-cristal mono-hidrato de fluconazol e acido fumárico.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)engUniversidade Federal de São CarlosCâmpus São CarlosPrograma de Pós-Graduação em Química - PPGQUFSCarAPIFluconazolCocristais farmaceticaEngenharia de cristaisRamanDRX de monocristalFluconazolePharmacutical cocrystalCrystal engineringPXRDSingle Crystal XRDCoformerCIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ANALITICASynthesis of new cocrystal solid form of fluconazole-fumaric acidinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisOnline6006007727504b-c3a5-48cf-a36e-390bbf474c99info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSCARinstname:Universidade Federal de São Carlos (UFSCAR)instacron:UFSCARORIGINALDissBCDO.pdfDissBCDO.pdfapplication/pdf4309058https://repositorio.ufscar.br/bitstreams/e30c5261-fc5a-4666-becd-00276345c1ba/download4f5cf3d0dbedd0e22b67ee37cbc653e9MD51trueAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81957https://repositorio.ufscar.br/bitstreams/a0af23a8-2121-4cb0-ab4b-0a85d4c62146/downloadae0398b6f8b235e40ad82cba6c50031dMD52falseAnonymousREADTEXTDissBCDO.pdf.txtDissBCDO.pdf.txtExtracted texttext/plain158886https://repositorio.ufscar.br/bitstreams/af63004e-fdfb-494a-be37-4450a96a512a/downloada97eb1b5572bfb555c23be628eff855dMD55falseAnonymousREADTHUMBNAILDissBCDO.pdf.jpgDissBCDO.pdf.jpgIM Thumbnailimage/jpeg6945https://repositorio.ufscar.br/bitstreams/b660d049-3cdb-4867-8fe0-633ad18d4adf/download0918e8ee960c2c94445e8303ab590f80MD56falseAnonymousREAD20.500.14289/85572025-02-05 17:30:45.391Acesso abertoopen.accessoai:repositorio.ufscar.br:20.500.14289/8557https://repositorio.ufscar.brRepositório InstitucionalPUBhttps://repositorio.ufscar.br/oai/requestrepositorio.sibi@ufscar.bropendoar:43222025-02-05T20:30:45Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)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
dc.title.eng.fl_str_mv Synthesis of new cocrystal solid form of fluconazole-fumaric acid
title Synthesis of new cocrystal solid form of fluconazole-fumaric acid
spellingShingle Synthesis of new cocrystal solid form of fluconazole-fumaric acid
Owoyemi, Bolaji Charles Dayo
API
Fluconazol
Cocristais farmacetica
Engenharia de cristais
Raman
DRX de monocristal
Fluconazole
Pharmacutical cocrystal
Crystal enginering
PXRD
Single Crystal XRD
Coformer
CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ANALITICA
title_short Synthesis of new cocrystal solid form of fluconazole-fumaric acid
title_full Synthesis of new cocrystal solid form of fluconazole-fumaric acid
title_fullStr Synthesis of new cocrystal solid form of fluconazole-fumaric acid
title_full_unstemmed Synthesis of new cocrystal solid form of fluconazole-fumaric acid
title_sort Synthesis of new cocrystal solid form of fluconazole-fumaric acid
author Owoyemi, Bolaji Charles Dayo
author_facet Owoyemi, Bolaji Charles Dayo
author_role author
dc.contributor.authorlattes.por.fl_str_mv http://lattes.cnpq.br/2811381246113757
dc.contributor.author.fl_str_mv Owoyemi, Bolaji Charles Dayo
dc.contributor.advisor1.fl_str_mv Carneiro, Renato Lajarim
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/8065852319463976
dc.contributor.authorID.fl_str_mv d09e37ac-a71f-4dee-9e8b-f47bca621de0
contributor_str_mv Carneiro, Renato Lajarim
dc.subject.por.fl_str_mv API
Fluconazol
Cocristais farmacetica
Engenharia de cristais
Raman
DRX de monocristal
topic API
Fluconazol
Cocristais farmacetica
Engenharia de cristais
Raman
DRX de monocristal
Fluconazole
Pharmacutical cocrystal
Crystal enginering
PXRD
Single Crystal XRD
Coformer
CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ANALITICA
dc.subject.eng.fl_str_mv Fluconazole
Pharmacutical cocrystal
Crystal enginering
PXRD
Single Crystal XRD
Coformer
dc.subject.cnpq.fl_str_mv CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ANALITICA
description Pharmaceutical cocrystals are multicomponent crystalline solids comprised of an active pharmaceutical ingredient (API) and one or more co-formers interacting through hydrogen bonding or other weak interactions like the π-stack and van der Waals interactions. Fluconazole (FLZ) is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. It is also used to prevent and treat meningitis. Cocrystallization is an alternative approach for enhancement of drug. It can be performed using neat grinding, solvent assisted grinding, solvent evaporation, cooling evaporation and slurry cocrystallization. In this work, a new cocrystal Fluconazol-Fumaric acid monohydrate was synthesized via 1:1 stoichiometric amount of FLZ and FUM at different conditions. The characterization of the synthesized cocrystals was achieved using Raman spectroscopy, differential scanning calorimetry, powder X-ray diffraction and single crystal X-ray diffraction. The results obtained for the characterization of the samples showed some obvious differences among the spectra, diffractograms and thermograms. The single crystal X-ray diffraction analysis of the new structure shows a cocrystal where the fluconazole molecules are attached to the fumaric acid and water molecules respectively through hydrogen bonds, gave unique cell dimensions for an assumed structure C17H18F2N6O6 with a space group of P21/n, a = 17.053(3) Å, b = 5.5995(10), c=21.154(3), α = 90°, β=105.418(4)°, γ= 90°, V = 1947.3(6) Å3. This work is the first to report a monohydrate cocrystal structure of fluconazole and fumaric acid.
publishDate 2015
dc.date.issued.fl_str_mv 2015-09-29
dc.date.accessioned.fl_str_mv 2017-03-13T18:20:51Z
dc.date.available.fl_str_mv 2017-03-13T18:20:51Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv OWOYEMI, Bolaji Charles Dayo. Synthesis of new cocrystal solid form of fluconazole-fumaric acid. 2015. Dissertação (Mestrado em Química) – Universidade Federal de São Carlos, São Carlos, 2015. Disponível em: https://repositorio.ufscar.br/handle/20.500.14289/8557.
dc.identifier.uri.fl_str_mv https://repositorio.ufscar.br/handle/20.500.14289/8557
identifier_str_mv OWOYEMI, Bolaji Charles Dayo. Synthesis of new cocrystal solid form of fluconazole-fumaric acid. 2015. Dissertação (Mestrado em Química) – Universidade Federal de São Carlos, São Carlos, 2015. Disponível em: https://repositorio.ufscar.br/handle/20.500.14289/8557.
url https://repositorio.ufscar.br/handle/20.500.14289/8557
dc.language.iso.fl_str_mv eng
language eng
dc.relation.confidence.fl_str_mv 600
600
dc.relation.authority.fl_str_mv 7727504b-c3a5-48cf-a36e-390bbf474c99
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Química - PPGQ
dc.publisher.initials.fl_str_mv UFSCar
publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFSCAR
instname:Universidade Federal de São Carlos (UFSCAR)
instacron:UFSCAR
instname_str Universidade Federal de São Carlos (UFSCAR)
instacron_str UFSCAR
institution UFSCAR
reponame_str Repositório Institucional da UFSCAR
collection Repositório Institucional da UFSCAR
bitstream.url.fl_str_mv https://repositorio.ufscar.br/bitstreams/e30c5261-fc5a-4666-becd-00276345c1ba/download
https://repositorio.ufscar.br/bitstreams/a0af23a8-2121-4cb0-ab4b-0a85d4c62146/download
https://repositorio.ufscar.br/bitstreams/af63004e-fdfb-494a-be37-4450a96a512a/download
https://repositorio.ufscar.br/bitstreams/b660d049-3cdb-4867-8fe0-633ad18d4adf/download
bitstream.checksum.fl_str_mv 4f5cf3d0dbedd0e22b67ee37cbc653e9
ae0398b6f8b235e40ad82cba6c50031d
a97eb1b5572bfb555c23be628eff855d
0918e8ee960c2c94445e8303ab590f80
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)
repository.mail.fl_str_mv repositorio.sibi@ufscar.br
_version_ 1851688753847861248